# 5719
Although we often see research and discussions on multidrug resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) bacteria, a bit surprisingly there aren’t any universally accepted definitions for the above terms.
Since such ambiguities compromise the ability of scientists to review and compare research data, an international panel of experts has been assembled by the ECDC and the CDC, tasked with coming up with standardized definitions.
This press release from the ECDC.
27 Jul 2011
Emergence of resistance to multiple antimicrobial agents in pathogenic bacteria has become a significant public health threat. As this problem continues to grow, harmonised definitions to describe and classify bacteria that are resistant to multiple antimicrobial agents are needed, so that epidemiological surveillance data can be reliably collected and compared across healthcare settings and countries.
A group of international experts came together by a joint initiative by the European Centre for Disease Prevention and Control (ECDC) and the United States Centers for Disease Control and Prevention (CDC), to create a standardised international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp., Enterobacteriaceae (other than Salmonella and Shigella), Pseudomonas aeruginosa, and Acinetobacter spp., all bacteria often responsible for healthcare-associated infections and prone to multidrug resistance.
Read more:
The definitions are published in Clinical Microbiology and Infection and are openly accessible.
Updates of the definitions will, when performed, be posted on this page hosted by ECDC.
You’ll find worksheets designed to classify S. aureus, Enterococcus spp., Enterobacteriaceae (other than Salmonella and Shigella) , Pseudomonas aeruginosa , and Acinetobacter spp. at this link.
For those interested in the details and the work that went into defining these terms, you can read the entire article in today’s Journal of Clinical Microbiology and Infection:
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A.-P. Magiorakos,A. Srinivasan, R. B. Carey, Y. Carmeli, M. E. Falagas, C. G. Giske, S. Harbarth, J. F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, D. L. Paterson, L. B. Rice, J. Stelling, M. J. Struelens, A. Vatopoulos, J. T. Weber, D. L. Monnet
For a quick reference, I’ve created a mash up of some of the highlights of the tables.
Related Post:
- CHP: Review Of NDM-1 In Hong Kong
- A Health Crisis In Slow Motion
- India: Still Looking For A Policy On Antibiotics
- Study: Antimicrobial Prescribing Practices During The 2009 Pandemic
- NDM-1: A Matter Of Import
- Referral: McKenna Times Four
- HPA: Healthcare-Associated Infection (HCAI) Survey
- Chan: World Faces A `Post-Antibiotic Era’
- WHO: The Evolving Threat Of Antimicrobial Resistance
- Get Smart About Antibiotics Week
- South African Statement On NDM-1 Cases
- India: The NDM-1 Story Continues
- India Puts Antibiotic Regulations On Hold
- CDDEP: Mapping Resistance
- NDM-1: One Year Later
- Netherlands: Large Nosocomial KPC Outbreak
- Going, Going, Gonorrhea
- The Path Of Increased Resistance
- Referral: McKenna On Drug Resistant E. Coli And Chickens
- More On Hong Kong's Scarlet Fever Outbreak
- When Old Bacteria Learns New Tricks
- Study: Sub-Therapeutic Antibiotic Exposure Drives Resistance
- UK: `New MRSA’ Strain Spreading
- India Looks For (And Finds) NDM-1
- Do1Thing: A 12 Step Preparedness Program
- CDC FluView Week 52
- CDC Statement On This Year’s Flu Activity
- CDC HAN Update On Fungal Meningitis Outbreak
- Referral: McKenna On The Steroid-Linked Meningitis Outbreak
- NIVW 2012
- Early Flu Cases Begin To Emerge
- MMWR: Yosemite Hantavirus
- CDC Update Of Fungal Meningitis Cases
- A Health Crisis In Slow Motion
- UK: Norovirus Season Starts Early
- MMWR: Carbon Monoxide Exposures Related To Hurricane Sandy
- Peru: Alert For Bubonic Plague In Ascope Region
- CDC HAN Advisory: Additional NECC Products Found Contaminated
- CDC: Laboratory Test Results From Meningitis Outbreak
- FDA Statement On Conditions Reported At NECC Facility
- CDC Fungal Meningitis Update – Oct. 26th
- Preparing For After The Storm Passes
- The UK’s Whooping Cough Outbreak
- CDC HAN Advisory & Updates On Fungal Meningitis
- CDC Fungal Meningitis Update – Oct 22nd
- CDC Fungal Meningitis Update – Oct 19th
- CDC Fungal Meningitis Update – Oct 18th
- Detailed Report On Fatal Meningitis Case
- CDC Fungal Meningitis Update – Oct 17th
- ECDC: Multidrug Resistant Infections Increasing In Europe
- CHP: Review Of NDM-1 In Hong Kong
- Referral: McKenna On Resistant Gonorrhea
- Study: Antimicrobial Prescribing Practices During The 2009 Pandemic
- ECDC Response Plan To Multi-Drug Resistant Gonorrhea
- WHO: Urgent Action Needed On Resistant Gonorrhea
- Referral: McKenna Times Four
- HPA: Healthcare-Associated Infection (HCAI) Survey
- FDA Statement On Azithromycin & Cardiovascular Risks
- NEJM: Cardiovascular Risks Of Taking Azithromycin
- Video: Maryn McKenna On Antibiotic Resistance
- ECDC Comment On Drug Resistant TB In India
- Get Smart About Antibiotics Week
- CDDEP: Mapping Resistance
- NDM-1: One Year Later
- The Global Spread Of Drug Resistant Salmonella
- Study: Prior Antibiotic Use & MRSA In Children
- IDSA: Educational Guidelines Lower Antibiotic Use
- Going, Going, Gonorrhea
- The Path Of Increased Resistance
- Updating Hong Kong’s Scarlet Fever Outbreak
- When Old Bacteria Learns New Tricks
- Study: Sub-Therapeutic Antibiotic Exposure Drives Resistance
- UK: `New MRSA’ Strain Spreading
Widget by [ Iptek-4u ]